IMR Press / CEOG / Special Issues / 1596175650622

Obesity in pregnancy: risks and management

Section: Pregnancy
Submission deadline: 28 February 2021
Special Issue Editor
  • Gideon Koren, MD
    Adelson faculty of medicine, Ariel University, and Motherisk Israel Program, Shamir Hospital, Israel
    Interests: Clinical pharmacology During development; Drugs in pregnancy
Special Issue Information

Dear Colleagues,

Obesity in pregnancy is associated with serious adverse maternal and fetal effects, including infertility, gestational diabetes, preeclampsia, intrauterine fetal and neonatal death, neural tube defects and many other.  Because the prevalence of obesity in pregnancy has been steadily increased over the last few decades, its health impacts are much more serious. According to the World Health Organization, It has been estimated that overweight and obesity affect over 50 million women globally in upper and middle income countries. In the United States, a third of the women are obese and the yearly number of obese pregnant women exceeds 1 million.

Obesity-related hyperinsulinemia and subsequent hyperandrogenemia increase the risk of anovulatory cycles and the chance of conception decreases. Obesity is associated with increased risk of caesarian section, premature placental abruption, perineal tear, puerperal fever, severe puerperal infections, would healing complications, complications of obstetric anesthesia, postpartum hemorrhage, sepsis, obstetric shock, ICU admission and combined severe maternal morbidity and mortality. Maternal obesity is associated with long term overweight retention and its attendant long term morbidity with diabetes mellitus and cardiovascular risks. Maternal overweight and obesity are associated with increased risks for congenital malformations such as neural tube defects, cardiovascular risks, hydrocephaly, oral cleft and limb reduction anomalies.

In this special issue, leading scientists will be addressing emerging knowledge related to important challenges in evaluating, preventing and managing obesity in pregnancy, with focus on short and long term maternal risks, child risks, congenital malformations and pharmacological and non- pharmacological management.

Prof. Gideon Koren

Guest Editor

Maternal risks
Fetal risks
Long term risks
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Planned Paper (3 Papers)
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to IMR Press journals will subject to peer-review before acceptance

Maternal high fat diet and fetal programming of obesity

Seray Kabaran

Analysis of selected diet components

Grazyna Jarząk-Bielecka

Patient with Martin-Bell syndrome and premenstrual syndrome, tendency to obesity from puberty

razyna Jarząk-Bielecka

Published Paper (6 Papers)
Back to top